Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
The nuclear receptor superfamily includes ligand-inducible transcription factors that play diverse roles in cell metabolism and are associated with pathologies such as cardiovascular diseases. Lysophosphatidic acid (LPA) belongs to a family of lipid mediators. LPA and its naturally occurring analogu...
Main Authors: | Tamotsu Tsukahara, Yoshikazu Matsuda, Hisao Haniu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/12/2730 |
Similar Items
-
Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders
by: Tatsuya Karaki, et al.
Published: (2022-12-01) -
Lysophospholipids–potent candidates for brain food, protects neuronal cells against α-Synuclein aggregation
by: Tatsuya Karaki, et al.
Published: (2022-12-01) -
Therapeutic Potential of Porcine Liver Decomposition Product: New Insights and Perspectives for Microglia-Mediated Neuroinflammation in Neurodegenerative Diseases
by: Tamotsu Tsukahara, et al.
Published: (2020-10-01) -
PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01) -
Gardenia jasminoides J. Ellis extract GJ-4 attenuates hyperlipidemic vascular dementia in rats via regulating PPAR-γ-mediated microglial polarization
by: Hui Liu, et al.
Published: (2022-07-01)